Recombinant human tissue kallikrein

Drug identity checked against registry records

Also recorded as DM199

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)NCT05065216DMACPhase 2, Phase 3Recruiting2026-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.